IPSC logo

Century Therapeutics, Inc. Common Stock


IPSC: Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.


Show IPSC Financials

Consumer Interest
SEC Filings

Recent trades of IPSC by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by IPSC's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Artificial cell death polypeptide for chimeric antigen receptor and uses thereof May. 30, 2023
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of IPSC in WallStreetBets Daily Discussion


Recent insights relating to IPSC

CNBC Recommendations

Recent picks made for IPSC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IPSC

Corporate Flights

Flights by private jets registered to IPSC